M. Kahan

发表

Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction.

D. Lane, H. Ireland, P. Stubbs, 2000, Blood.

The effect of tumour necrosis factor-α (TNF-α) muteins on human neutrophils in vitro

M. Feldmann, E. Paleolog, P. Parniewski, 1993, Mediators of inflammation.

TNF The effect of tumour necrosis factor-= ( TN F-= ) muteins on human neutrophils in vitro

Feldmann, Jarosz, Zeman, 2022 .

Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.

A. Cope, M. Feldmann, D. Wallach, 1995, Immunology.

Themajority oftheactivated T cells inthebloodof insulin-dependent diabetes mellitus (IDDM)patients areCD4+

M. Feldmann, M. Londei, M. Kahan, 1988 .

Preferential expression of Vβ6.7 domain on human peripheral CD4+ T cells. Implication for positive selection of T cells in man

C. Franceschi, A. Cossarizza, M. Londei, 1991 .

Interleukin‐10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl‐2

M. Feldmann, B. Foxwell, S. Cohen, 1997, Immunology.

The effects of tumor necrosis factor (TNF) derivatives on TNF receptors.

M. Feldmann, F. Brennan, E. Paleolog, 1993, Cytokine.

Expression of the identical V beta gene in human T-cell clones does not confer the same pattern of responsiveness to bacterial enterotoxins.

S. Quaratino, M. Londei, A. Verhoef, 1993, Immunology.

Specific Interactions between a Human CD4+ Clone and Autologous CD4+ Bifunctional Immunoregulatory Clones

J. Lamb, M. Feldmann, D. Naor, 1990, Immunological reviews.

Interactions between autologous T cell clones.

M. Feldmann, D. Naor, N. Tarcic, 1990, Cellular immunology.

Human serum amyloid P component protects against Escherichia coli O157:H7 Shiga toxin 2 in vivo: therapeutic implications for hemolytic-uremic syndrome.

C. Sabin, P. Marcato, G. Armstrong, 2006, The Journal of infectious diseases.

PUVA therapy decreases HLA‐DR+ CD1a+ Langerhans cells and epidermal cell antigen‐presenting capacity in human skin, but flow cytometrically‐sorted residual HLA‐DR+ CD1a+Langerhans cells exhibit normal alloantigen‐presenting function

S. Breathnach, M. Kahan, J. Ashworth, 1989, The British journal of dermatology.

Regulatory Interactions among Autologous T Cell Clones Human Bifunctional T Cell Clones Regulate the Activity of an Autologous T Cell Clone a

M. Feldmann, D. Naor, N. Tarcic, 1991, Annals of the New York Academy of Sciences.

Definition of unique traits of human CD4− CD8−αβ T cells

S. Quaratino, M. Londei, A. Verhoef, 1993 .

Flow cytometrically-sorted residual HLA-DR+T6+ Langerhans cells in topical steroid-treated human skin express normal amounts of HLA-DR and CD1a/T6 antigens and exhibit normal alloantigen-presenting capacity.

S. Breathnach, M. Kahan, J. Ashworth, 1989, The Journal of investigative dermatology.

in Mice against Acute Lipopolysaccharide Challenge Human C-Reactive Protein Does Not Protect

M. Pepys, G. Hirschfield, J. Herbert, 2003 .

Induction of hapten recognizing helper function by heavily trinitrophenylated sheep erythrocytes.

R. Laskov, D. Naor, M. Kahan, 1976, Advances in experimental medicine and biology.

Single-step immunosorbent preparation of F-protein from mouse liver with conservation of the allo-antigenic site, and determination of concentration in liver and serum.

L. Wedderburn, N. Nardi, M. Lukic, 1984, Molecular immunology.

Targeting C-reactive protein for the treatment of cardiovascular disease

Steven V. Ley, Carol V. Robinson, Darren Thompson, 2006, Nature.

Flow cytometric analysis and sorting of HLA‐DR+CD1+ Langerhans cells

S. Breathnach, M. Kahan, J. Ashworth, 1989, The British journal of dermatology.

Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

A. Petrie, G. Taylor, M. Pepys, 2010, Nature.

Studies on the immune response to fixed antigens. Preferential induction of helper function with heavily trinitrophenylated sheep erythrocytes, and glutaraldehyde-treated sheep erythrocytes.

D. Naor, M. Kahan, R. Saltoun, 1976, Journal of immunology.

T-cell clone anti-clone interactions. Effects on suppressor and helper activities.

M. Feldmann, D. Naor, M. Kahan, 1989, Journal of autoimmunity.

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

C. Sabin, M. Pepys, G. Tennent, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice.

C. Sabin, M. Pepys, G. Tennent, 2008, Atherosclerosis.

Human C-Reactive Protein Does Not Protect against Acute Lipopolysaccharide Challenge in Mice 1

M. Pepys, G. Hirschfield, J. Herbert, 2003, The Journal of Immunology.

Precise CD4 T-cell counting using red diode laser excitation: for richer, for poorer.

George Janossy, Ilesh V Jani, G. Janossy, 2002, Cytometry.

Differential effects of interleukin‐10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony‐stimulating factor/interleukin‐4

M. Londei, H. Thomssen, M. Kahan, 1995, European journal of immunology.

EVIDENCE THAT RAPAMYCIN HAS DIFFERENTIAL EFFECTS ON IL‐4 FUNCTION: MULTIPLE IL‐4 SIGNALING PATHWAYS AND IMPLICATIONS FOR IN VIVO USE

B. Foxwell, M. Ritter, P. Hiestand, 1993, Transplantation.

Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself

C. Sabin, M. Pepys, P. Hawkins, 2005, Circulation research.

Definition of unique traits of human CD4-CD8- alpha beta T cells.

S. Quaratino, M. Londei, A. Verhoef, 1993, Clinical and experimental immunology.

CD5 (Ly-1)-negative, conventional splenic B cells make a substantial contribution to the bromelain plaque-forming cell response in CBA and BW mice.

R. Maini, E. Andrew, M. Kahan, 1990, Immunology.

The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.

M. Feldmann, M. Londei, E. Gale, 1988, Clinical and experimental immunology.